Koninklijke Philips | Des Atouts



Assets Changement Date
Abbott USD 81.41B 7.06B 2024-12
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Danaher USD 79.12B 1.57B 2025-03
Demant DKK 32.45B 60M 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Fresenius EUR 43.55B 1.18B 2024-12
General Electric USD 124.12B 983M 2025-03
Getinge SEK 63.92B 4.3B 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
GN Store Nord DKK 21.68B 7.9B 2024-12
Hitachi JPY 13.28T 381.8B 2025-03
Hologic USD 8.73B 427.3M 2024-12
Idexx Laboratories USD 3.29B 57.32M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 19.22B 477.2M 2025-03
J&J USD 180.1B 1.82B 2024-12
Koninklijke Philips EUR 28.98B 498M 2024-12
Masimo USD 2.63B 462.1M 2024-12
Medtronic USD 89.97B 69M 2025-01
Philips EUR 28.98B 498M 2024-12
ResMed USD 7.57B 425.49M 2025-03
Smith & Nephew USD 10.35B 188M 2024-12
Steris USD 10.01B 233.78M 2024-12
Stryker USD 42.97B 862M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Terumo JPY 1.88T 125.37B 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Koninklijke Philips Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.